Abstract
Low birth efficiency and developmental abnormalities in embryos derived using round spermatid injection (ROSI) limit the clinical application of this method. In this study, embryonic day (E) 11.5 mouse fetuses and corresponding placentas derived from ROSI, intracytoplasmic sperm injection (ICSI), and natural in vivo fertilization (control) were analyzed. Transcriptome and DNA methylation profiles were compared using RNA-sequencing (RNA-seq) and whole-genome bisulfite sequencing (WGBS). Results revealed similar gene expression profiles across all groups, though specific differentially expressed genes (DEGs) were identified: seven in ROSI fetuses and ten in ROSI placentas. No significant differences in CpG methylation or imprinting control region methylation were observed. While 49 repetitive DNA sequences (RS) were abnormally activated in ROSI fetuses, their DNA methylation remained normal. These findings suggest that while ROSI-derived embryos are largely comparable to controls at mid-pregnancy, specific gene expression anomalies warrant further investigation.
Introduction
For individuals with non-obstructive azoospermia, Round Spermatid Injection (ROSI) provides a pathway to biological fatherhood by utilizing immature sperm cells. Despite its potential, ROSI is characterized by lower birth efficiency and a higher incidence of developmental abnormalities compared to Intracytoplasmic Sperm Injection (ICSI). The molecular mechanisms driving these discrepancies—whether due to epigenetic reprogramming failures or transcriptomic errors—have remained largely unknown. This study addresses this gap by performing a comprehensive molecular characterization of ROSI-derived mouse offspring at the critical mid-pregnancy stage (E11.5).
Methodology
The researchers compared three experimental groups: ROSI-derived embryos, ICSI-derived embryos (the clinical standard), and naturally fertilized controls. The study utilized RNA-sequencing (RNA-seq) to profile gene expression in both the fetus and placenta, and Whole-Genome Bisulfite Sequencing (WGBS) to map DNA methylation at single-base resolution. Findings were validated using qRT-PCR. The resulting datasets, including transcriptomic profiles of 16 fetuses and 16 placentas, are archived in the Genome Sequence Archive (GSA) under accession CRA003905.
Results
Global Molecular Stability
The primary finding of the study is the remarkable molecular similarity between ROSI-derived fetuses and their naturally conceived counterparts. Hierarchical clustering of transcriptomic data showed that samples clustered primarily by tissue type (fetus vs. placenta) rather than by fertilization method, indicating that the fundamental developmental program remains intact in ROSI embryos.
Identification of Differentially Expressed Genes (DEGs)
Despite global stability, the study identified a small set of genes that were consistently misregulated in the ROSI group. Specifically, 7 DEGs were found in ROSI fetuses and 10 DEGs in ROSI placentas when compared to both ICSI and control groups. Notable placental DEGs included Ctss (Cathepsin S), which plays a role in placental development. Validation by qRT-PCR confirmed the abnormal expression levels of several genes, including Snhg11, Meg3, Ctss, and H2-Eb1.
Epigenetic Profiles and Repetitive Sequences
DNA methylation analysis revealed no widespread differences in CpG methylation across the three groups. Methylation at Imprinting Control Regions (ICRs) was also found to be normal. However, the researchers observed the abnormal activation of 49 repetitive DNA sequences (RS) in ROSI fetuses. Interestingly, the methylation levels of these RS regions were unaffected, suggesting that other epigenetic mechanisms, such as histone modifications, may be responsible for the failure to silence these genomic elements.
Discussion and Future Directions
The study provides a reassuring view of the molecular safety of ROSI at mid-pregnancy, but highlights specific vulnerabilities. A "runt" ROSI fetus with significant growth retardation exhibited hypermethylation and low expression of Fggy and Rec8, suggesting these genes could serve as biomarkers for developmental failure.
While the results suggest that ROSI embryos are largely normal by E11.5, the authors note that earlier developmental stages (pre-implantation) should be investigated to determine if more severe abnormalities occur and are subsequently filtered out. Furthermore, future research should explore other epigenetic layers, such as 3D chromatin architecture, to fully understand the impact of using immature sperm in assisted reproduction.
Summary updated